Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma

We report asialoglycoprotein receptor (ASGPR)-targeted doxorubicin hydrochloride (Dox) nanoparticles (NPs) for hepatocellular carcinoma (HCC). Polyethylene sebacate (PES)-Gantrez® AN 119 Dox NPs of average size 220 nm with PDI < 0.62 and ∼20% Dox loading were prepared by modified nanoprecipitatio...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Drug Deliv
Prif Awduron: Pranatharthiharan, Sandhya, Patel, Mitesh D., Malshe, Vinod C., Pujari, Vaishali, Gorakshakar, Ajit, Madkaikar, Manisha, Ghosh, Kanjaksha, Devarajan, Padma V.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Taylor & Francis 2017
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8244555/
https://ncbi.nlm.nih.gov/pubmed/28155331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2016.1225856
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg